Stopped: Transition to BioMetabol
Development of a new mass spectrometry-based biomarker for the early and sensitive diagnosis of Gaucher Disease from blood (plasma)
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Sequencing of the Gaucher disease related gene
Timeframe: 4 weeks